Skip to Main Content

Author Details

Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
2010
86
36
PMIDPaper TitleJournal TitlePublished Year
34756793Corrigendum to "Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients" [Cytokine 148 (2021) 155662].Cytokine2022
35598394Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection.Virology2022
36327219Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative.PLoS Genet2022
35121493Elevated plasma levels of CXCL16 in severe COVID-19 patients.Cytokine2022
33330999Neurokinin-1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial.J Eur Acad Dermatol Venereol2021
34551289PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation.Cell Rep2021
34353696Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'.Cytokine2021
33421484Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis.J Am Acad Dermatol2021
31413096Genomics of therapy-related myeloid neoplasms.Haematologica2020
32004386Distinctive and common features of moderate aplastic anaemia.Br J Haematol2020
31911633Rare germline variant contributions to myeloid malignancy susceptibility.Leukemia2020
32361028Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.Int J Antimicrob Agents2020
30618304<i>BCOR</i> and <i>BCORL1</i> mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes.Leuk Lymphoma2019
31869410Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.Blood Adv2019
31772163Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.Nat Commun2019
31358855The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine.Leukemia2019
31320321Distinct clinical and biological implications of <i>CUX1</i> in myeloid neoplasms.Blood Adv2019
31288594Misidentification of <i>MLL3</i> and other mutations in cancer due to highly homologous genomic regions.Leuk Lymphoma2019
31018124Development of a Cx46 Targeting Strategy for Cancer Stem Cells.Cell Rep2019
30898763Subclonal STAT3 mutations solidify clonal dominance.Blood Adv2019
31070582Gene-centric functional dissection of human genetic variation uncovers regulators of hematopoiesis.Elife2019
30709865Invariant phenotype and molecular association of biallelic <i>TET2</i> mutant myeloid neoplasia.Blood Adv2019
30655603Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes.Bone Marrow Transplant2019
29339439<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors.Clin Cancer Res2018
30015632Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates.J Clin Invest2018
30322869Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes.Blood2018
29749402Clonal PIGA mosaicism and dynamics in paroxysmal nocturnal hemoglobinuria.Leukemia2018
29795413Consequences of mutant TET2 on clonality and subclonal hierarchy.Leukemia2018
29797327Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.Br J Haematol2018
28935992Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms.Leukemia2018
29099495A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia.Leukemia2018
29321554Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.Blood Cancer J2018
29217782Rational management approach to pure red cell aplasia.Haematologica2018
27992414Dynamics of clonal evolution in myelodysplastic syndromes.Nat Genet2017
28111468Deletion of Ptpn1 induces myeloproliferative neoplasm.Leukemia2017
28255022Molecular features of early onset adult myelodysplastic syndrome.Haematologica2017
28223278Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation.Blood2017
28318095Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34).Int J Lab Hematol2017
29416752Fanconi Anemia germline variants as susceptibility factors in aplastic anemia, MDS and AML.Oncotarget2017
28650479AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.Nat Cell Biol2017
28555081Genomic determinants of chronic myelomonocytic leukemia.Leukemia2017
28893734Origins of myelodysplastic syndromes after aplastic anemia.Blood2017
28819282Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.Leukemia2017
28862700Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes.Blood Cancer J2017
28758902GATA4 loss of function in liver cancer impedes precursor to hepatocyte transition.J Clin Invest2017
28031539Recurrent genetic defects on chromosome 5q in myeloid neoplasms.Oncotarget2017
27773925Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms.Leukemia2017
26205084Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development.Leukemia2016
26574844Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.Am J Surg Pathol2016
27983727The complexity of interpreting genomic data in patients with acute myeloid leukemia.Blood Cancer J2016
  • 1 - 50 of 86

Recommended Authors

Aarif M N Batcha
Institute for Medical Information Processing
Career Start Year 2015
Number of shared co-authors 9
Fiorella Schischlik
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 2
Il??ana Antony-Debr??
INSERM, France Villejuif Universite Paris-Saclay
Career Start Year 2011
Number of shared co-authors 1
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 2
Tamara L Lamprecht
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 0
Simone Feurstein
University Hospital Heidelberg
Career Start Year 2010
Number of shared co-authors 4
Christopher A Miller
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Jennifer Dunlap
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 0
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 15
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Catrina Fronick
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 2
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 3
Anna L Brown
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 7
Michelle O'Laughlin
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 2
Sharon E Heath
Washington University School of Medicine.
Career Start Year 2003
Number of shared co-authors 1
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 1
Gudrun G??hring
Hannover Medical School
Career Start Year 2002
Number of shared co-authors 11
Fei Yang
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 1
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Rafael Bejar
Moores Cancer Center, university of california san diego
Career Start Year 2001
Number of shared co-authors 8
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 5
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 6
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 9
Matthew J Walter
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 8
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 6
Jean Soulier
University of Paris
Career Start Year 1993
Number of shared co-authors 3
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 1

Collaborators

Seishi Ogawa
Kyoto University
Co-authored papers 19
Satoru Miyano
Tokyo Medical and Dental University
Co-authored papers 14
Hiroko Tanaka
Tokyo Medical and Dental University
Co-authored papers 10
Sandra P Smieszek
Vanda Pharmaceuticals Inc.
Co-authored papers 9
Thomas LaFramboise
Co-authored papers 9
Torsten Haferlach
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 6
Alison R Moliterno
Johns Hopkins Hospital
Co-authored papers 3
Luca Malcovati
University of Pavia & S. Matteo Hospital
Co-authored papers 3
Hiromichi Suzuki
Graduate School of Medicine, Kyoto University
Co-authored papers 3
Hans-Ulrich Klein
Columbia University Irving Medical Center
Co-authored papers 3
Cyrus Khandanpour
University Hospital of Muenster
Co-authored papers 2
Wolfgang E Berdel
University Hospital Munster
Co-authored papers 2
Alexander Kanapin
Co-authored papers 2
Tarik M??r??y
Institut de recherches cliniques de Montreal
Co-authored papers 2
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 2
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 2
Szymon Pula
Co-authored papers 1
Timothy Sanders
David Geffen School of Medicine, University of California-Los Angeles
Co-authored papers 1
Nicole Simons
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Efren Sandoval
Co-authored papers 1
Carlo Rivolta
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Co-authored papers 1
Monnat Pongpanich
Chulalongkorn University
Co-authored papers 1
Joseph D Buxbaum
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Francisco Tanudjaja
Co-authored papers 1
Mateusz Sypniewski
MNM Bioscience Inc.
Co-authored papers 1
Yanara Marincevic-Zuniga
Uppsala University
Co-authored papers 1
Alexandre Bolze
The Rockefeller University
Co-authored papers 1
Shaun Dabe
Co-authored papers 1
Ebtehal A Alsolm
King Fahad Medical City and King Abdulaziz City for Science and Technology
Co-authored papers 1
Tatsuhiko Naito
Osaka University Graduate School of Medicine
Co-authored papers 1
Release 1.2